| Growth factor release from tissue engineering scaffolds MJ Whitaker, RA Quirk, SM Howdle, KM Shakesheff Journal of Pharmacy and Pharmacology 53 (11), 1427-1437, 2001 | 358 | 2001 |
| Applications of supercritical CO2 in the fabrication of polymer systems for drug delivery and tissue engineering OR Davies, AL Lewis, MJ Whitaker, H Tai, KM Shakesheff, SM Howdle Advanced drug delivery reviews 60 (3), 373-387, 2008 | 357 | 2008 |
| Supercritical fluid mixing: preparation of thermally sensitive polymer composites containing bioactive materialsElectronic supplementary information (ESI) available: methods … SM Howdle, MS Watson, MJ Whitaker, VK Popov, MC Davies, FS Mandel, ... Chemical Communications, 109-110, 2001 | 263 | 2001 |
| Three-dimensional bioactive and biodegradable scaffolds fabricated by surface-selective laser sintering EN Antonov, VN Bagratashvili, MJ Whitaker, JJA Barry, KM Shakesheff, ... Advanced materials (Deerfield Beach, Fla.) 17 (3), 327, 2004 | 178 | 2004 |
| A phase 2 study of Chronocort, a modified-release formulation of hydrocortisone, in the treatment of adults with classic congenital adrenal hyperplasia A Mallappa, N Sinaii, P Kumar, MJ Whitaker, LA Daley, D Digweed, ... The Journal of Clinical Endocrinology & Metabolism 100 (3), 1137-1145, 2015 | 170 | 2015 |
| Characterisation of microcellular foams produced from semi-crystalline PCL using supercritical carbon dioxide MJ Jenkins, KL Harrison, M Silva, MJ Whitaker, KM Shakesheff, ... European Polymer Journal 42 (11), 3145-3151, 2006 | 164 | 2006 |
| Human osteoprogenitor bone formation using encapsulated bone morphogenetic protein 2 in porous polymer scaffolds XB Yang, MJ Whitaker, W Sebald, N Clarke, SM Howdle, KM Shakesheff, ... Tissue engineering 10 (7-8), 1037-1045, 2004 | 163 | 2004 |
| Drug delivery goes supercritical PJ Ginty, MJ Whitaker, KM Shakesheff, SM Howdle Materials today 8 (8), 42-48, 2005 | 157 | 2005 |
| The production of protein-loaded microparticles by supercritical fluid enhanced mixing and spraying MJ Whitaker, J Hao, OR Davies, G Serhatkulu, S Stolnik-Trenkic, ... Journal of Controlled Release 101 (1-3), 85-92, 2005 | 130 | 2005 |
| Salivary cortisone reflects cortisol exposure under physiological conditions and after hydrocortisone M Debono, RF Harrison, MJ Whitaker, D Eckland, W Arlt, BG Keevil, ... The Journal of Clinical Endocrinology & Metabolism 101 (4), 1469-1477, 2016 | 110 | 2016 |
| An oral multiparticulate, modified‐release, hydrocortisone replacement therapy that provides physiological cortisol exposure MJ Whitaker, M Debono, H Huatan, DP Merke, W Arlt, RJ Ross Clinical endocrinology 80 (4), 554-561, 2014 | 110 | 2014 |
| Incorporation of proteins into polymer materials by a novel supercritical fluid processing method MS Watson, MJ Whitaker, SM Howdle, KM Shakesheff Advanced Materials 14 (24), 1802-1804, 2002 | 78 | 2002 |
| Poor compliance and increased mortality, depression and healthcare costs in patients with congenital adrenal hyperplasia S Jenkins-Jones, L Parviainen, J Porter, MJ Whitaker, SE Holden, ... European journal of endocrinology 178 (4), 309-320, 2018 | 73 | 2018 |
| Polymer composite with internally distributed deposition matter S Howdle, K Shakesheff, M Whitaker, M Watson US Patent App. 10/506,618, 2005 | 73 | 2005 |
| Plasticization and spraying of poly (DL‐lactic acid) using supercritical carbon dioxide: control of particle size J Hao, MJ Whitaker, B Wong, G Serhatkulu, KM Shakesheff, SM Howdle Journal of pharmaceutical sciences 93 (4), 1083-1090, 2004 | 69 | 2004 |
| Absorption and tolerability of taste‐masked hydrocortisone granules in neonates, infants and children under 6 years of age with adrenal insufficiency U Neumann, MJ Whitaker, S Wiegand, H Krude, J Porter, M Davies, ... Clinical Endocrinology 88 (1), 21-29, 2018 | 65 | 2018 |
| Modified-release and conventional glucocorticoids and diurnal androgen excretion in congenital adrenal hyperplasia CM Jones, A Mallappa, N Reisch, N Nikolaou, N Krone, BA Hughes, ... The Journal of Clinical Endocrinology & Metabolism 102 (6), 1797-1806, 2017 | 65 | 2017 |
| Mammalian cell survival and processing in supercritical CO2 PJ Ginty, D Howard, FRAJ Rose, MJ Whitaker, JJA Barry, P Tighe, ... Proceedings of the National Academy of Sciences 103 (19), 7426-7431, 2006 | 62 | 2006 |
| Quality of compounded hydrocortisone capsules used in the treatment of children U Neumann, D Burau, S Spielmann, MJ Whitaker, RJ Ross, C Kloft, ... European journal of endocrinology 177 (2), 239-242, 2017 | 58 | 2017 |
| Development and testing in healthy adults of oral hydrocortisone granules with taste masking for the treatment of neonates and infants with adrenal insufficiency MJ Whitaker, S Spielmann, D Digweed, H Huatan, D Eckland, ... The Journal of Clinical Endocrinology & Metabolism 100 (4), 1681-1688, 2015 | 52 | 2015 |
Andrew Lewiscritical pharmaceuticals, Ipsen, University of Queensland, University of NottinghamZweryfikowany adres z quotientclinical.com
